Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. biocopy

BIOCOPY SIGNED

BIOCOPY: the new biomolecule copying and screening solution for diagnostics and therapeutics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 BIOCOPY project word cloud

Explore the words cloud of the BIOCOPY project. It provides you a very rough idea of what is the project "BIOCOPY" about.

biocopy    biosensors    opens    disruptive    label    tailor    generation    drug    days    describing    obtaining    candidates    biotech    therapeutics    copy    analogous    first    expertise    2019    billion    freiburg    approval    biomolecules    discovery    acute    free    copied    milestone    engineering    business    physics    diagnostics    payments    microsystems    protein    mixes    dimensions    dollar    market    5m    spin    royalty    annum    biology    binding    revenues    surface    upfront    patented    rna    antibodies    photocopier    technological    feasibility    company    coatings    bioactive    plan    completely    services    off    made    template    technique    2025    innovative    world    clinical    molecular    pharmaceuticals    manufacturing    60    assay    11    projected    line    screenings    borned    output    academic    awarded    character    responsible    catalysts    100    dna    recovered    university    covers    vaccines    companies    either    biochemical    commercialization    coated    team    transfer    vaccine    cheaper    biotechnology    molecules    enzymes    pharma    supplying   

Project "BIOCOPY" data sheet

The following table provides information about the project.

Coordinator		 BIOCOPY GMBH 

Organization address
address: SPECHTWEG 25
city: FREIBURG IM BREISGAU
postcode: 79110
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Germany [DE]
 Project website http://www.biocopy.de/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2018-09-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    BIOCOPY GMBH DE (FREIBURG IM BREISGAU) coordinator 50˙000.00

Map

 Project objective

'BioCopy is a spin-off company borned in the University of Freiburg. We have developed an innovative, patented technique to copy biomolecules analogous to a photocopier. A DNA-coated surface is used as copy template. By supplying different biochemical 'copy mixes', either a DNA, a RNA or a protein copy is generated. After the copy process, the copied biomolecules can be analyzed label-free for their specific binding to target molecules and recovered as potential candidates for a future use as therapeutics or diagnostics. The BioCopy technology completely opens up new dimensions for drug development, vaccines, antibodies, enzymes, catalysts, bioactive coatings, and biosensors and it has are more than 40 future applications. We plan to offer 3 products and services to pharma and biotech companies, related with high- output and cheaper molecular biology screenings. The most promising line is the tailor-made discovery of vaccine candidates within two days. This will have a disruptive character, because the first generation of a vaccine is a billion-dollar market, projected to rise $60 billion on 2019, with 11% growth per annum, and to $100 billion by 2025. BioCopy will provide vaccine candidates to pharmaceuticals, obtaining revenues through upfront, milestone and royalty payments, and they will be responsible for the vaccine´s clinical development, approval and distribution. The multi-awarded BioCopy team covers business know-how and expertise in biology, physics, manufacturing systems engineering, assay development and microsystems technology. BioCopy aims to contribute to the European challenges related with advanced biotechnology applications in pharma sector, and to increase the technological transfer from the academic world into the manufacturing sector. During phase 1 we will build up a detailed business plan and a feasibility study, describing all the needed activities in order to reach BioCopy commercialization. We will need about €2.5M in phase 2.'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOCOPY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOCOPY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More  

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More